| Scorecard |
|---|
|
3 / 5 Stars
|
|
Lipper
2
2
5
5
3
|
|
Zacks Investment Research
4
(Sell)
|
|
Standard & Poor's
---
|
|
TheStreet.com
D+
(Sell)
|
Fund Holdings
The fund invests in undervalued companies. Management currently likes healthcare stocks and is staying away from big banks.
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 22.98 | 22.98 |
| Stocks | 76.37 | 76.37 |
| Bonds | 0.0 | 0.0 |
| Other | 0.65 | 0.65 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 0.0 | 0.0 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 12.31.2012
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 12.31.2012
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Exxon Mobil Corporation | XOM | 1.77 | 3.53 |
| CVS Caremark Corp | CVS | 22.44 | 3.5 |
| Chevron Corp | CVX | 12.05 | 3.46 |
| Microsoft Corporation | MSFT | 23.36 | 3.28 |
| Travelers Companies, Inc. | TRV | 17.74 | 3.27 |
| 3M Co | MMM | 13.28 | 3.25 |
| Altria Group Inc. | MO | 16.92 | 3.24 |
| Amgen Inc | AMGN | 21.82 | 3.18 |
| Kroger Co | KR | 32.01 | 3.12 |
| Johnson & Johnson | JNJ | 21.03 | 3.01 |
